SCHEMBL29346151

SCHEMBL29346151

Cc1cc(OBO)ccc1C[C@](C)(N)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
BLM P54132 2/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP1A2 P05177 2/20 0.40
KDM4E B2RXH2 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
USP2 O75604 1/20 0.40
EGFR P00533 1/20 0.40
FYN P06241 1/20 0.40
POLB P06746 1/20 0.40
CYP3A4 P08684 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
APEX1 P27695 1/20 0.40
ADRA1A P35348 1/20 0.40
PTGS2 P35354 1/20 0.40
MTOR P42345 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29346152 1.00 MEN1 (0.40) MEN1KMT2ABLMALDH1A1CYP1A2
SCHEMBL29346181 0.86 BLM (0.40) MEN1KMT2ABLMALDH1A1CYP1A2
SCHEMBL29346150 0.85 BLM (0.40) MEN1KMT2ABLMALDH1A1CYP1A2
SCHEMBL29346158 0.85 ALDH1A1 (0.40) MEN1KMT2ABLMALDH1A1CYP1A2
SCHEMBL29346160 0.85 ALDH1A1 (0.40) MEN1KMT2ABLMALDH1A1CYP1A2
SCHEMBL29346149 0.85 BLM (0.40) MEN1KMT2ABLMALDH1A1CYP1A2
SCHEMBL29346155 0.84 MEN1 (0.39) MEN1KMT2ABLMALDH1A1CYP1A2
SCHEMBL29346157 0.84 MEN1 (0.39) MEN1KMT2ABLMALDH1A1CYP1A2
SCHEMBL29346154 0.83 EPHX2 (0.40) MEN1KMT2ABLMALDH1A1CYP1A2
SCHEMBL29346185 0.83 BLM (0.38) MEN1KMT2ABLMALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239816-A1 BORONO-PHENYLALANINE DERIVATIVE STELLA PHARMA CORPORATION (JP) 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239816-A1 BORONO-PHENYLALANINE DERIVATIVE SLC7A1, SLC1A5, LATS2 MEN1 1675/4885KMT2A 2381/4885BLM 3131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.